AZN News and Press, AstraZeneca PLC From 01/08/24

Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer PR Newswire HOLON, Israel , Jan. 8, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinica...

2024-01-07 07:15:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The market bounced in ...

2024-01-05 15:45:11 ET Summary AstraZeneca plans to acquire Icosavax for $15/share in cash and one non-tradable CVR per share. The CVR pays out $4/share upon FDA approval of the vaccine candidate and $1/share upon achieving over $200M in sales. The CVR is currently fairly valu...

2024-01-05 14:31:55 ET More on AstraZeneca, Eli Lilly, etc. Profiting From Obesity Drugs HRTS, Novo Nordisk And Eli Lilly Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgra...

2024-01-05 09:07:57 ET More on Big Pharma Bristol-Myers Squibb Company (BMY) Management presents at Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Merck & Co., Inc. (MRK) Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Bri...

2024-01-04 23:40:00 ET Summary AstraZeneca will acquire Chinese cell therapy maker Gracell for up to $1.2 billion, representing an 86% premium to the company’s pre-announcement share price. The U.S. FDA announced an investigation into a potential severe risk of T-cell malig...

2024-01-04 13:51:02 ET More on BioNTech, Moderna, etc. Pfizer: If You Missed The Pandemic Entry, Here's Another Chance BioNTech's Strategic Shift: Diversifying Into Cancer Therapeutics The Pfizer Advantage: High Dividend Yield, JN.1 Variant, And Therapeutic Innovatio...

2024-01-02 10:46:48 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Voyager Therapeutics (NASDAQ: VYGR ) stock is up by more than 25% today after the company agreed to a licensing deal with Novartis (NYSE: NVS ). Novartis wil...

2024-01-02 09:28:01 ET AstraZeneca ( NASDAQ: AZN ) has entered into an exclusive option and global license deal with biotechnology company Allorion Therapeutics. The deal provides AstraZeneca ( AZN ) with an exclusive option to license a novel epidermal growth factor rec...

2023-12-31 01:55:00 ET Summary Elpiscience Biopharma forms a $1.7 billion collaboration with Astellas Pharma to develop a bispecific macrophage engager. AstraZeneca acquires Gracell Biotech in a deal worth up to $1.2 billion, including a clinical stage CAR-T therapy. Jinan Qil...